- $6.50m
- $5.43m
- $16.00m
- 75
- 97
- 57
- 90
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.24 | ||
| Price to Tang. Book | 2.62 | ||
| Price to Free Cashflow | 2.88 | ||
| Price to Sales | 0.41 | ||
| EV to EBITDA | 1.51 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 108.91% | ||
| Return on Equity | 291.82% | ||
| Operating Margin | 20.99% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 53.7 | 24.43 | 20.05 | 16.2 | 16 | n/a | n/a | -19.8% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company's hemp extracts and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). It also operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based therapeutics. It develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under brands, such as +PlusCBD and Cultured Foods in the healthcare market sector, including nutraceutical, beauty care, specialty foods, and pet products. Its +PlusCBD branded products are sold at select retail locations throughout the United States. The Company's Cultured Foods brand provides a variety of 100% plant-based food products and caters to individuals seeking vegan, gluten-free, or flexitarian options for a culinary experience.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- July 26th, 2013
- Public Since
- October 4th, 2018
- No. of Shareholders
- 36
- No. of Employees
- 42
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Pink Sheets on Nasdaq- Shares in Issue
- 163,228,469
- Address
- 9530 PADGETT STREET, SUITE 107, SAN DIEGO, 92126
- Web
- https://cvsciences.com/
- Phone
- Auditors
- Haskell & White LLP
Upcoming Events for CVSI
CV Sciences Inc Annual Shareholders Meeting
CV Sciences Inc Annual Shareholders Meeting
Q2 2024 CV Sciences Inc Earnings Release
Similar to CVSI
Acacia Diversified Holdings
Pink Sheets on Nasdaq
Acusphere
Pink Sheets on Nasdaq
Adorbs
Pink Sheets on Nasdaq
Agentix
Pink Sheets on Nasdaq
Agrios Global Holdings
Pink Sheets on Nasdaq
FAQ
What is the CV Sciences share price?
As of Today at 19:06 UTC, shares in CV Sciences are trading at $0.04. This share price information is delayed by 15 minutes.
How has the CV Sciences share price performed this year?
Shares in CV Sciences last closed at $0.04 and the price had moved by -9.34% over the past 365 days. In terms of relative price strength the CV Sciences share price has underperformed the S&P500 Index by -20.01% over the past year.
What are the analyst and broker recommendations for CV Sciences?
The overall consensus recommendation for CV Sciences is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the CV Sciences dividend yield?
CV Sciences does not currently pay a dividend.
Does CV Sciences pay a dividend?
CV Sciences does not currently pay a dividend.
When does CV Sciences next pay dividends?
CV Sciences does not currently pay a dividend.
How do I buy CV Sciences shares?
To buy shares in CV Sciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of CV Sciences?
As of the previous close price of $0.04, shares in CV Sciences had a market capitalisation of $6.50m.
Where are CV Sciences shares listed?
Here are the trading details for CV Sciences:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: CVSI
What kind of share is CV Sciences?
Based on an overall assessment of its quality, value and momentum CV Sciences is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a CV Sciences share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the CV Sciences share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CV Sciences. Over the past six months, its share price has underperformed the S&P500 Index by -9.71%.
As of the last closing price of $0.04, shares in CV Sciences were trading +2.32% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the CV Sciences PE Ratio?
The CV Sciences PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.04.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of CV Sciences?
We do not have data on CV Sciences' directors